Pediatric Endocrine Disorders

47 soru

Soru 21Soru →

A 4-day-old male infant is brought to the emergency department due to poor feeding, excessive sleepiness, and jittery movements. He was born at 39 weeks of gestation via uncomplicated vaginal delivery to a 28-year-old primigravid mother. Vital signs show a temperature of 36.1°C (97.0°F), heart rate of 165/min, respiratory rate of 45/min, and blood pressure of 58/36 mmHg. Physical examination reveals a lethargic neonate with mild scleral icterus. Genitourinary examination shows bilateral nonpalpable testes and a stretched penile length of 1.4 cm (normal for term > 2.5 cm). Laboratory studies reveal a capillary blood glucose of 34 mg/dL. He is given an intravenous dextrose bolus with improvement in his symptoms. Additional laboratory results are as follows:

Laboratory TestResultReference Range
Sodium132 mEq/L135-145 mEq/L
Potassium4.2 mEq/L3.5-5.5 mEq/L
Chloride98 mEq/L98-106 mEq/L
Bicarbonate20 mEq/L20-28 mEq/L

Which of the following is the most likely diagnosis?

Cevabı ve açıklamayı göster

Cevap: Congenital hypopituitarism

Cevap

Congenital hypopituitarism
The correct answer is congenital hypopituitarism. This patient presents with panhypopituitarism, which classically manifests in the neonatal period with a triad of hypoglycemia (due to growth hormone and adrenocorticotropic hormone [ACTH] deficiency), micropenis with cryptorchidism (due to luteinizing hormone [LH] and follicle-stimulating hormone [FSH] deficiency), and prolonged jaundice (due to thyroid-stimulating hormone [TSH] deficiency). The laboratory findings show hypoglycemia and hyponatremia. Hyponatremia occurs because cortisol normally suppresses antidiuretic hormone (ADH); a lack of cortisol leads to elevated ADH and subsequent free water retention. Crucially, the serum potassium is normal. In ACTH deficiency (secondary adrenal insufficiency), aldosterone production is preserved because it is primarily regulated by the renin-angiotensin-aldosterone system (RAAS) and serum potassium levels, not ACTH. This intact mineralocorticoid function prevents hyperkalemia, distinguishing hypopituitarism from primary adrenal insufficiency.

Adım Adım Çözüm

1
Identify signs of severe metabolic derangement.
The infant presents with severe hypoglycemia (34 mg/dL) and hyponatremia (132 mEq/L), indicating a deficiency in counter-regulatory hormones such as cortisol and/or growth hormone.
Recognizing these metabolic abnormalities narrows the differential diagnosis to adrenal or pituitary etiologies.
2
Analyze the serum potassium level.
The serum potassium is perfectly normal (4.2 mEq/L).
A normal potassium level suggests intact aldosterone secretion. This rules out primary adrenal insufficiency (such as classic congenital adrenal hyperplasia) and points toward secondary (pituitary) adrenal insufficiency, where the renin-angiotensin-aldosterone system remains functional.
3
Correlate metabolic findings with the genitourinary examination.
The presence of a micropenis and bilateral nonpalpable testes indicates a deficiency in fetal testosterone during the second and third trimesters, a process driven by fetal pituitary LH.
Combining secondary adrenal insufficiency with LH/FSH deficiency (and likely TSH deficiency causing the prolonged jaundice) firmly establishes the diagnosis of panhypopituitarism.

Anahtar Kavram

Neonatal presentation of panhypopituitarism
Soru 22Soru →

Match each pediatric patient's clinical presentation with the most likely underlying diagnosis.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 6-year-old girl with declining linear growth velocity, weight gain, cold intolerance, and a firm, symmetrically enlarged thyroid gland.
A 7-year-old girl with early breast bud development, pubic hair, accelerated linear growth, and an advanced bone age.
A 10-year-old boy with new-onset enuresis, excessive thirst, and an unexplained 3-kg (6.6-lb) weight loss over the past month.
A 5-year-old boy whose height has dropped from the 50th to the 5th percentile over two years, with delayed bone age but normal weight gain.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct pairings match each classic symptom cluster to its corresponding disease: the child with goiter and poor growth has autoimmune thyroiditis; the child with early sexual development has central precocious puberty; the child with enuresis and weight loss has type 1 diabetes mellitus; and the child with isolated growth deceleration has growth hormone deficiency.
Each clinical vignette provides classic, unambiguous hallmark symptoms of a distinct pediatric endocrine disorder, allowing for direct recognition of the underlying pathology based on standard diagnostic criteria.

Adım Adım Çözüm

1
Analyze the 6-year-old girl's presentation.
Identified declining growth, weight gain, cold intolerance, and a goiter.
These are the textbook systemic features of acquired hypothyroidism, primarily caused by autoimmune thyroiditis in this age group.
2
Analyze the 7-year-old girl's presentation.
Identified early breast development, accelerated growth, and advanced bone age.
These findings confirm early activation of the hypothalamic-pituitary-gonadal axis, defining central precocious puberty.
3
Analyze the 10-year-old boy's presentation.
Identified new-onset enuresis, extreme thirst, and weight loss.
Enuresis acts as a marker for polyuria; combined with polydipsia and weight loss, this is the classic triad of type 1 diabetes mellitus.
4
Analyze the 5-year-old boy's presentation.
Identified an isolated height drop across major percentiles with delayed bone age.
This specific growth pattern is the hallmark of growth hormone deficiency.

Anahtar Kavram

Recognizing the hallmark clinical presentations of common pediatric endocrine disorders.
Soru 23Soru →

A 6-year-old girl is brought to the pediatric endocrinology clinic by her parents due to breast development and rapid growth over the past 6 months. Physical examination reveals Tanner stage 3 breast development and Tanner stage 2 pubic hair. Her height has recently crossed from the 50th to the 95th percentile for age. Assuming her evaluation ultimately leads to a diagnosis of idiopathic central precocious puberty requiring pharmacotherapy, arrange the following clinical steps in the correct chronological order from initial diagnostic evaluation to final management.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence is: 1) Assess bone age, 2) Measure basal LH/FSH, 3) Perform GnRH stimulation test, 4) Obtain brain MRI, 5) Initiate GnRH agonist therapy.
The evaluation of precocious puberty follows a strict, step-wise algorithm designed to minimize unnecessary or invasive testing. The initial step is always assessing skeletal maturation (bone age) to differentiate true precocious puberty from isolated premature thelarche or adrenarche. Once advanced bone age confirms true precocious puberty, the source of sex steroids must be localized. This is done by measuring basal gonadotropins (LH/FSH). Because basal LH can be prepubertal in the early stages of central precocious puberty, a GnRH stimulation test is often the necessary subsequent step to biochemically confirm central activation. Once central precocious puberty is proven, a brain MRI is mandatory in girls younger than 8 years to rule out an underlying central nervous system lesion (such as a hypothalamic hamartoma). If the MRI is negative, the diagnosis is idiopathic central precocious puberty, and the final step is initiating treatment with a long-acting GnRH agonist to arrest pubertal progression and preserve adult height potential.

Adım Adım Çözüm

1
Differentiate true precocious puberty from benign premature thelarche.
Obtain a bone age radiograph.
Rapid linear growth and breast development require confirmation of skeletal advancement before invasive hormone testing.
2
Determine if the precocious puberty is centrally or peripherally driven.
Measure basal LH and FSH.
High basal LH indicates a central etiology, while low LH indicates peripheral etiology or early central puberty.
3
Confirm central activation if basal LH is equivocal or prepubertal.
Perform a GnRH stimulation test.
A pubertal LH response to GnRH stimulation definitively diagnoses central precocious puberty.
4
Rule out intracranial pathology causing the central activation.
Obtain a brain MRI.
Girls under 8 years with confirmed central precocious puberty have a significant risk of CNS lesions (e.g., hypothalamic hamartoma, tumors).
5
Manage the idiopathic central precocious puberty.
Initiate long-acting GnRH agonist therapy.
Continuous administration of a GnRH agonist downregulates pituitary GnRH receptors, suppressing gonadotropin release and halting early puberty.

Anahtar Kavram

The diagnostic algorithm for central precocious puberty begins with a bone age assessment, followed by basal and stimulated gonadotropin testing, neuroimaging to rule out CNS tumors, and finally, medical suppression with a GnRH agonist.
Tahmini Süre:1m 30s
Soru 24Soru →

A 6-year-old girl is brought to the clinic by her parents due to bilateral breast development and a recent rapid increase in height. Her past medical history is unremarkable. Physical examination reveals Tanner stage 3 breast development and Tanner stage 2 pubic hair. Assume each subsequent test in her workup yields findings that require progression to the next definitive step in the standard diagnostic and therapeutic algorithm for central precocious puberty.

Arrange the following steps in the most appropriate sequential order for the evaluation and management of this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence for evaluating precocious puberty is: 1) Bone age radiograph, 2) Basal LH measurement, 3) GnRH stimulation test, 4) Brain MRI, 5) GnRH agonist therapy.
The standard algorithmic approach to early pubertal development begins with a bone age radiograph to assess for advanced skeletal maturation, which signifies prolonged exposure to sex steroids. Once advanced bone age is confirmed, basal LH levels are drawn to distinguish central (gonadotropin-dependent) from peripheral (gonadotropin-independent) precocious puberty. If basal LH is low or equivocal but suspicion remains high, a GnRH stimulation test is required to definitively demonstrate activation of the hypothalamic-pituitary-gonadal axis. Upon confirming central precocious puberty, a brain MRI is strictly indicated (especially in girls under 8 years of age and all boys) to rule out central nervous system lesions such as hypothalamic hamartomas. Finally, once central tumors are ruled out or addressed, continuous GnRH agonist therapy is initiated to suppress the axis, halt pubertal progression, and preserve adult height potential.

Adım Adım Çözüm

1
Determine bone age.
Identifies advanced skeletal maturation.
Differentiates true precocious puberty from benign premature thelarche or premature adrenarche.
2
Measure basal LH.
Determines if precocious puberty is gonadotropin-dependent.
High LH indicates central precocious puberty; low or equivocal LH requires further dynamic stimulation testing.
3
Perform GnRH stimulation test.
A pubertal LH response confirms central precocious puberty.
Required when basal LH is equivocal or in the prepubertal range despite clinical signs and advanced bone age.
4
Obtain brain MRI.
Evaluates for central nervous system lesions.
Mandatory in girls under 8 years and all boys with confirmed central precocious puberty to rule out hypothalamic hamartomas or other tumors.
5
Initiate continuous GnRH agonist.
Suppresses the hypothalamic-pituitary-gonadal axis.
Halts pubertal progression and prevents premature epiphyseal fusion after pathological causes are ruled out.

Anahtar Kavram

The diagnostic algorithm for central precocious puberty prioritizes distinguishing benign variants from true precocity, confirming hypothalamic-pituitary-gonadal axis activation, ruling out central nervous system lesions, and finally initiating suppressive therapy.
Soru 25Soru →

A 77-year-old female patient is seen in the pediatric endocrinology office for an evaluation of early physical maturation. The parents first noticed the development of breast tissue about 88 months ago. Recently, she has outgrown her clothes much faster than her peers. On physical examination, her height is at the 9595 th percentile, whereas she had historically tracked along the 5050 th percentile. She has Tanner stage 33 breasts and Tanner stage 22 pubic hair. Radiographic assessment of the left wrist indicates a skeletal age of 1010 years. A random serum luteinizing hormone (LH) level is markedly elevated. Which of the following is the most appropriate next step in the evaluation of this patient?

Cevabı ve açıklamayı göster

Cevap: Magnetic resonance imaging of the brain

Cevap

Magnetic resonance imaging of the brain
The correct answer is magnetic resonance imaging (MRI) of the brain. This patient presents with precocious puberty, defined as the onset of secondary sexual characteristics before age 88 in girls. The evaluation of precocious puberty begins with a bone age radiograph. Because her bone age is advanced (1010 years compared to a chronological age of 77), she has true precocious puberty. The next step is evaluating luteinizing hormone (LH) levels. An elevated baseline LH level confirms central (gonadotropin-dependent) precocious puberty, indicating premature activation of the hypothalamic-pituitary-gonadal axis. All patients with central precocious puberty require an MRI of the brain to rule out central nervous system lesions, such as a hypothalamic hamartoma, before initiating therapy with a GnRH agonist.

Adım Adım Çözüm

1
Identify the patient's condition based on clinical presentation.
The patient has early breast development and pubic hair before age 88, indicating precocious puberty.
Recognizing precocious puberty is the first step to determining the appropriate diagnostic algorithm.
2
Interpret the diagnostic test results provided in the stem.
The bone age is advanced (1010 years vs chronological 77 years), confirming true precocious puberty. The baseline LH is elevated, confirming a gonadotropin-dependent (central) etiology.
Advanced bone age differentiates true precocious puberty from isolated premature thelarche. Elevated LH differentiates central from peripheral causes.
3
Determine the required next step in management for central precocious puberty.
Magnetic resonance imaging of the brain is the next indicated step.
Central precocious puberty can be idiopathic, but it is frequently caused by central nervous system tumors (e.g., hypothalamic hamartomas), which must be ruled out.

Anahtar Kavram

Evaluation of central precocious puberty requires a brain MRI to rule out CNS lesions before initiating treatment.
Tahmini Süre:1m 0s
Soru 26Soru →

A macrosomic male infant born at 3939 weeks gestation develops persistent hypoglycemia. At 2424 hours of life, despite receiving a continuous intravenous infusion of 10%10\% dextrose at a glucose infusion rate (GIR) of 88 mg/kg/min, his point-of-care blood glucose is 4040 mg/dL. He is lethargic but maintaining his airway and hemodynamic stability. The medical team suspects congenital hyperinsulinism and prepares to definitively evaluate and manage his condition.

Arrange the following steps in the optimal sequential order for the diagnostic workup and management of this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is: 1) Draw a critical sample while glucose is <50< 50 mg/dL, 2) Administer glucagon to evaluate response and rescue glucose, 3) Titrate the GIR to maintain normoglycemia, 4) Initiate an oral diazoxide trial, and 5) Perform an 18F-DOPA PET scan if medical therapy fails.
The algorithm for persistent neonatal hypoglycemia is highly strict. A critical sample must be drawn first while the glucose is low to capture the inappropriate hormonal milieu. Glucagon is given immediately afterward to both confirm the diagnosis (via an exaggerated glycemic response) and protect the brain. Once the diagnosis is secured and acute rescue is provided, the continuous GIR is titrated to maintain stability. Diazoxide is then started as definitive medical therapy. If diazoxide fails over several days, surgical planning with 18F-DOPA PET and genetics is indicated.

Adım Adım Çözüm

1
Secure diagnostic evidence of hyperinsulinism.
Critical sample is drawn while glucose is <50< 50 mg/dL.
Insulin and counterregulatory hormones must be measured during active hypoglycemia to prove inappropriate secretion.
2
Perform a diagnostic and therapeutic glucagon challenge.
Glucagon is administered immediately following the critical blood draw.
Glucagon frees hepatic glycogen stores, rapidly correcting the hypoglycemia while confirming the diagnosis of hyperinsulinism (indicated by a Δ\Delta glucose >30> 30 mg/dL).
3
Establish continuous metabolic stability.
The intravenous GIR is titrated upward to 12−1512-15 mg/kg/min.
Continuous high-concentration dextrose is required to match the excessive peripheral glucose uptake driven by hyperinsulinism until long-term medications take effect.
4
Begin long-term medical management.
Oral diazoxide therapy is initiated.
Diazoxide prevents insulin release by keeping K-ATP channels open, serving as the definitive first-line medication.
5
Prepare for surgical intervention if refractory.
18F-DOPA PET imaging and genetic testing (e.g., ABCC8, KCNJ11) are ordered.
Patients failing medical therapy require pancreatectomy. PET scans accurately differentiate focal from diffuse disease to guide the surgical approach.

Anahtar Kavram

The evaluation of persistent neonatal hypoglycemia requires drawing a critical laboratory sample during active hypoglycemia (<50< 50 mg/dL), followed immediately by acute reversal (glucagon and high GIR) before initiating long-term medical (diazoxide) or surgical (guided by PET scan) interventions.
Soru 27Soru →

Pair the following pediatric clinical presentations and laboratory findings with their corresponding endocrine diagnoses.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 7-year-old boy with height below the 3rd percentile, normal growth velocity, bone age equal to chronological age, and parents with below-average heights.
A 13-year-old boy with height below the 5th percentile, delayed bone age, normal growth velocity for his bone age, and a father who grew significantly during college.
A 6-year-old girl with bilateral breast development, advanced bone age, and a luteinizing hormone level that surges following gonadotropin-releasing hormone stimulation.
A 9-year-old girl with declining linear growth velocity, increased weight percentiles, delayed bone age, and an elevated thyroid-stimulating hormone level.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct matches align normal bone age with familial short stature, delayed bone age with constitutional delay, LH surge with central precocious puberty, and growth deceleration with elevated TSH with acquired primary hypothyroidism.
Each clinical profile uniquely aligns with a specific pediatric endocrine disorder by evaluating bone age (normal in familial short stature, delayed in constitutional delay and hypothyroidism, advanced in precocious puberty), growth velocity (normal in normal variants, decreased in hypothyroidism), and hormonal axis activation (LH surge in central precocious puberty).

Adım Adım Çözüm

1
Analyze the growth and puberty parameters for the 7-year-old boy.
The patient has short stature but normal growth velocity and normal bone age, with a family history of short stature.
This pattern eliminates systemic diseases or intrinsic endocrine defects, pointing directly to familial short stature.
2
Evaluate the 13-year-old boy's growth pattern and family history.
The patient has delayed bone age with normal growth velocity for that delayed age, plus a family history of delayed puberty.
This classic 'late bloomer' profile is diagnostic of constitutional delay of growth and puberty.
3
Assess the hormonal and skeletal findings of the 6-year-old girl.
Thelarche at age 6 with advanced bone age and an LH surge after GnRH stimulation.
The LH surge confirms central (gonadotropin-dependent) precocious puberty rather than peripheral sources of sex steroids.
4
Interpret the growth deceleration and laboratory findings of the 9-year-old girl.
Declining linear growth, weight gain, delayed bone age, and elevated TSH.
These findings are the classic presentation of acquired primary hypothyroidism, most commonly Hashimoto thyroiditis in this age group.

Anahtar Kavram

Differentiating pediatric growth and puberty disorders based on bone age, growth velocity, and targeted hormonal testing.
Tahmini Süre:1m 30s
Soru 28Soru →

Review the following pediatric case scenarios involving abnormal physical findings or thyroid function laboratory results. Pair each patient profile with the correct underlying endocrine etiology.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 4-year-old child presents with attention deficits and a resting heart rate of 125/min; serum evaluation reveals high TSH and high free T4.
An infant at 6 weeks of age is noted to have an umbilical hernia and prolonged jaundice; serum evaluation reveals high TSH and low free T4.
An asymptomatic 5-year-old growing along the 50th percentile undergoes routine screening showing high total T4, with completely normal free T4 and TSH levels.
A 3-day-old newborn experiences recurrent hypoglycemia and is noted to have a micropenis; serum evaluation reveals low free T4 and inappropriately low TSH.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct sequence of matches is: the 4-year-old with tachycardia matches Resistance to thyroid hormone; the 6-week-old with an umbilical hernia matches Primary congenital hypothyroidism; the asymptomatic 5-year-old matches Thyroxine-binding globulin excess; and the 3-day-old with a micropenis matches Congenital hypopituitarism.
Each patient's clinical scenario demonstrates a specific, unique dysfunction in the hypothalamic-pituitary-thyroid axis, combined with pathognomonic phenotypic signs that secure the diagnosis.

Adım Adım Çözüm

1
Analyze the laboratory and clinical presentation for the 4-year-old child.
The combination of unsuppressed (high) TSH and high free T4, alongside hyperthyroid symptoms like tachycardia, points to a receptor-level issue.
This specific discordant pattern indicates Resistance to thyroid hormone, where the pituitary fails to sense the elevated T4, continuing to secrete TSH.
2
Evaluate the clinical signs and lab values for the 6-week-old infant.
Elevated TSH with low free T4 and classic signs (hernia, prolonged jaundice) indicates intrinsic thyroid gland failure.
Primary congenital hypothyroidism is the direct result of an absent or dysgenetic thyroid gland failing to produce sufficient T4, which drives up TSH via intact negative feedback.
3
Interpret the isolated elevation of total T4 in the 5-year-old.
The presence of elevated total T4 with completely normal free T4 and TSH confirms a change in transport proteins rather than actual thyroid disease.
Thyroxine-binding globulin excess purely expands the bound pool of hormone without altering the biologically active free state or the feedback loop.
4
Assess the multi-system presentation of the 3-day-old newborn.
Low free T4 without a TSH elevation (central hypothyroidism) combined with signs of GH/ACTH deficiency (hypoglycemia) and gonadotropin deficiency (micropenis) indicates a central failure.
Congenital hypopituitarism impairs the production of multiple anterior pituitary hormones, perfectly explaining this broad and severe phenotypic presentation.

Anahtar Kavram

Differentiation of pediatric endocrine disorders based on thyroid function test patterns and pathognomonic clinical signs.
Soru 29Soru →

A 9-year-old boy is brought to the clinic for evaluation of poor growth. Over the past 2 years, his height has decreased from the 50th to the 5th percentile, while his weight has increased from the 50th to the 75th percentile. The patient also complains of being constantly tired, feeling cold, and waking up 3 to 4 times a night to urinate and drink water. He has no significant past medical history. His temperature is 36.2∘C36.2^\circ\text{C}, blood pressure is 90/60 mmHg90/60\text{ mmHg}, and pulse is 58/min58/\text{min}. Physical examination shows dry skin and delayed relaxation of the deep tendon reflexes. He is at Tanner stage 1 for pubic hair and genital development.

Laboratory results are as follows:

TestResultReference Range
Serum sodium149 mEq/L149\text{ mEq/L}135−145 mEq/L135-145\text{ mEq/L}
Serum osmolality312 mOsm/kg H2O312\text{ mOsm/kg H}_2\text{O}275−295 mOsm/kg H2O275-295\text{ mOsm/kg H}_2\text{O}
Urine osmolality140 mOsm/kg H2O140\text{ mOsm/kg H}_2\text{O}>800 mOsm/kg H2O>800\text{ mOsm/kg H}_2\text{O} (with water deprivation)
Thyroid-stimulating hormone (TSH)0.2 \muU/mL0.2\text{ \mu U/mL}0.5−5.0 \muU/mL0.5-5.0\text{ \mu U/mL}
Free thyroxine (T4)0.6 ng/dL0.6\text{ ng/dL}0.9−2.3 ng/dL0.9-2.3\text{ ng/dL}

Which of the following is the most likely etiology of this patient's current condition?

Cevabı ve açıklamayı göster

Cevap: Cystic epithelial tumor arising from Rathke pouch remnants

Cevap

The most likely etiology is a cystic epithelial tumor arising from Rathke pouch remnants (craniopharyngioma).
The patient presents with signs of acquired hypothyroidism (fatigue, cold intolerance, weight gain, bradycardia, poor growth) and diabetes insipidus (polyuria, polydipsia, hypernatremia, dilute urine). The laboratory profile confirms central hypothyroidism (low free T4 and inappropriately low TSH) and diabetes insipidus. A lesion affecting both the pituitary and hypothalamus is necessary to cause this combination of findings. In children, a craniopharyngioma, which is a benign suprasellar tumor derived from the epithelial remnants of Rathke pouch, is the most common cause of acquired hypopituitarism and central diabetes insipidus. It compresses the pituitary stalk and functional tissue, leading to multiple hormone deficiencies.

Adım Adım Çözüm

1
Interpret the clinical symptoms and physical exam findings.
The patient exhibits growth failure, weight gain, fatigue, cold intolerance, bradycardia, and delayed reflex relaxation, which strongly suggest hypothyroidism. The severe polyuria, polydipsia, and nocturia suggest diabetes insipidus.
Identifying the clinical syndromes present is the first step in diagnosing complex endocrine disorders.
2
Analyze the laboratory results to determine the specific types of endocrine dysfunction.
A low free T4 with an inappropriately low TSH confirms central (secondary) hypothyroidism. Hypernatremia and elevated serum osmolality with a simultaneously low urine osmolality confirm central diabetes insipidus when considered with the hypopituitarism.
Laboratory confirmation distinguishes primary from secondary/central endocrine failure, which localizes the lesion.
3
Synthesize the findings to identify a single unifying diagnosis.
The combination of central hypothyroidism and central diabetes insipidus localizes the lesion to the hypothalamus or pituitary stalk. In a child, a craniopharyngioma (arising from Rathke pouch remnants) is the most common mass lesion causing panhypopituitarism.
A single etiology should explain all objective findings in a clinical vignette.

Anahtar Kavram

Craniopharyngioma presenting with panhypopituitarism
Soru 30Soru →

A 5-day-old female neonate is evaluated in the nursery for persistent tachycardia, irritability, and poor weight gain. She was born at 38 weeks gestation via spontaneous vaginal delivery. Her current weight is 2.8 kg, down from a birth weight of 3.2 kg. Vital signs show a temperature of 37.5∘C37.5^\circ\text{C} (99.5∘F99.5^\circ\text{F}), heart rate of 192/min192/\text{min}, and respiratory rate of 52/min52/\text{min}. Physical examination reveals a restless infant with warm, flushed skin and a wide-eyed stare. The mother has a history of Graves disease and was treated with a total thyroidectomy four years ago; she takes levothyroxine daily and maintained normal thyroid hormone levels throughout her pregnancy. Laboratory studies of the infant demonstrate a thyroid-stimulating hormone (TSH) level of <0.01 μU/mL<0.01\ \mu\text{U/mL} and an elevated free thyroxine (T4) level. Which of the following is the most likely underlying mechanism for this neonate's clinical presentation?

Cevabı ve açıklamayı göster

Cevap: Transplacental passage of maternal thyrotropin receptor antibodies

Cevap

Transplacental passage of maternal thyrotropin receptor antibodies
The correct answer identifies the transplacental passage of maternal thyrotropin receptor antibodies (TRAb). Graves disease is an autoimmune condition driven by IgG antibodies that stimulate the TSH receptor. Because IgG antibodies cross the placenta, a fetus can be subjected to continuous thyroid stimulation, resulting in neonatal thyrotoxicosis (neonatal Graves disease). Crucially, these antibodies can remain elevated in the maternal circulation for years after definitive treatment with radioactive iodine or total thyroidectomy, even if the mother is clinically euthyroid while on daily levothyroxine replacement.

Adım Adım Çözüm

1
Analyze the neonate's clinical presentation and laboratory findings.
The infant exhibits classic signs of hypermetabolism (tachycardia, irritability, excessive weight loss, warm skin) confirmed by a suppressed TSH and elevated free T4, diagnostic of neonatal thyrotoxicosis.
Establishing the functional thyroid status of the infant directs the search for the underlying etiology.
2
Evaluate the maternal history for a source of the neonatal endocrine dysfunction.
The mother has a history of Graves disease. Although she had a total thyroidectomy and is euthyroid on levothyroxine, her autoimmune condition implies she likely still produces thyrotropin receptor antibodies (TRAb).
Maternal history is the most critical factor in diagnosing neonatal thyroid disorders, as maternal factors often dictate neonatal outcomes.
3
Determine the pathophysiological link between the mother's immune status and the infant's thyrotoxicosis.
Maternal TRAb are IgG antibodies, which freely cross the placenta. These antibodies stimulate the fetal and neonatal thyroid gland, leading to the overproduction of thyroid hormones.
Understanding placental transfer dynamics (IgG crosses, TSH does not, T4 crosses poorly) is required to identify the correct mechanism.

Anahtar Kavram

Neonatal thyrotoxicosis (neonatal Graves disease) is caused by the transplacental passage of maternal thyrotropin receptor antibodies (IgG), which can persist in the maternal circulation for years even after definitive treatment (e.g., thyroidectomy or radioactive iodine) for Graves disease.

Alternatif Yöntem

Recognize the classic 'trap' presentation: a mother with a history of Graves disease who has been 'cured' via surgery or ablation but still harbors circulating IgG antibodies. The infant's thyrotoxicosis usually resolves spontaneously over a few months as the maternal IgG antibodies are degraded by the infant.
Tahmini Süre:1m 15s
Soru 31Soru →

An 88-year-old boy is brought to the emergency department by his parents due to abdominal pain, nausea, vomiting, and progressive lethargy over the past 2424 hours. The parents report that he has been drinking excessive amounts of water and urinating frequently for the past three weeks. On physical examination, he is lethargic but arousable, tachycardic, and has deep, rapid respirations with a fruity breath odor. Capillary blood glucose is measured at 480 mg/dL480 \text{ mg/dL}. Arrange the following steps in the most appropriate chronological sequence for the initial acute management of this patient's condition.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is: initial fluid resuscitation, verification of serum potassium, initiation of insulin infusion, addition of dextrose to intravenous fluids, and finally transitioning to subcutaneous insulin.
The management of pediatric diabetic ketoacidosis (DKA) follows a strict, step-wise protocol designed to slowly correct dehydration, hyperglycemia, and acidosis while minimizing the risk of cerebral edema and electrolyte derangements. The first and most critical step is restoring intravascular volume and organ perfusion with an initial fluid bolus of 0.9%0.9\% sodium chloride over 11 hour. Because insulin drives potassium into cells and can precipitate life-threatening arrhythmias, it is essential to verify that the serum potassium is greater than 3.3 mEq/L3.3 \text{ mEq/L} before initiating insulin therapy. Once fluids are underway and potassium is verified, a continuous intravenous infusion of regular insulin (0.05 to 0.1 U/kg/hr0.05 \text{ to } 0.1 \text{ U/kg/hr}) is started; an insulin bolus is contraindicated in pediatrics due to the risk of cerebral edema. As the insulin infusion corrects the hyperglycemia faster than it resolves the ketoacidosis, 5%5\% dextrose must be added to the intravenous fluids when the serum glucose drops to 250 to 300 mg/dL250 \text{ to } 300 \text{ mg/dL}. This prevents hypoglycemia and allows the insulin infusion to continue unabated to suppress ketogenesis. Finally, once the anion gap has closed (indicating resolution of ketoacidosis) and the patient is able to tolerate oral intake, the intravenous insulin is discontinued and the patient is transitioned to a subcutaneous insulin regimen.

Adım Adım Çözüm

1
Determine the patient's diagnosis based on the clinical presentation.
The presentation of polyuria, polydipsia, weight loss, Kussmaul respirations, and severe hyperglycemia is diagnostic of diabetic ketoacidosis (DKA).
Accurate diagnosis dictates the specific management protocol.
2
Identify the first priority in DKA management.
Volume resuscitation with 0.9%0.9\% sodium chloride.
Patients with DKA are severely volume-depleted due to osmotic diuresis.
3
Determine the prerequisites for starting insulin.
Serum potassium must be checked and confirmed to be >3.3 mEq/L>3.3 \text{ mEq/L}.
Insulin shifts potassium into cells; starting it in a severely hypokalemic patient can cause fatal arrhythmias.
4
Identify the next pharmacological step after fluids and potassium check.
Initiation of a continuous regular insulin infusion.
Insulin is required to stop ketogenesis and correct the acidosis.
5
Determine how to prevent hypoglycemia during continued insulin therapy.
Add 5%5\% dextrose to IV fluids when glucose falls to 250 to 300 mg/dL250 \text{ to } 300 \text{ mg/dL}.
Acidosis takes longer to resolve than hyperglycemia; dextrose allows continued insulin administration.
6
Identify the criteria for transitioning off IV insulin.
Transition to subcutaneous insulin when the anion gap closes and the patient can eat.
This indicates resolution of DKA and readiness for standard maintenance therapy.

Anahtar Kavram

Sequential management of pediatric diabetic ketoacidosis (DKA)
Soru 32Soru →

A 14-year-old boy is brought to the clinic for evaluation of worsening fatigue, cold intolerance, and constipation over the past 4 months. He has also experienced frequent morning nausea and lightheadedness when standing up quickly. His parents note that his growth has slowed significantly over the past year. Eight months ago, the patient was involved in a severe motor vehicle collision that resulted in a traumatic brain injury requiring a 3-week intensive care unit stay. His height is at the 15th percentile and his weight is at the 35th percentile. Blood pressure is 90/60 mm Hg90/60 \text{ mm Hg} while sitting and drops to 75/50 mm Hg75/50 \text{ mm Hg} upon standing.

Laboratory evaluation reveals:
- Sodium: 132 mEq/L132 \text{ mEq/L}
- Potassium: 4.0 mEq/L4.0 \text{ mEq/L}
- Thyroid-stimulating hormone (TSH): 1.4 \muU/mL1.4 \text{ \mu U/mL} (Normal: 0.5−4.5 \muU/mL0.5 - 4.5 \text{ \mu U/mL})
- Free T4: 0.5 ng/dL0.5 \text{ ng/dL} (Normal: 0.9−1.7 ng/dL0.9 - 1.7 \text{ ng/dL})

Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Assessment of serum cortisol and adrenocorticotropic hormone

Cevap

Assessment of serum cortisol and adrenocorticotropic hormone
The correct next step is to evaluate the patient's adrenal axis. This patient's laboratory profile (low free T4, inappropriately normal TSH) is diagnostic of central (secondary) hypothyroidism. Given his history of severe traumatic brain injury, he likely has panhypopituitarism. His clinical presentation—specifically orthostatic hypotension, morning nausea, and hyponatremia with normal potassium—strongly supports concurrent central adrenal insufficiency. In central adrenal insufficiency, ACTH is deficient, leading to low cortisol, but aldosterone remains intact as it is regulated by the renin-angiotensin-aldosterone system (hence the normal potassium). In any patient with suspected hypopituitarism, it is a critical medical rule that adrenal insufficiency must be evaluated and treated BEFORE initiating thyroid hormone replacement. Administering levothyroxine increases the basal metabolic rate and hepatic clearance of cortisol. If levothyroxine is given to a cortisol-deficient patient, it can rapidly precipitate a fatal adrenal crisis.

Adım Adım Çözüm

1
Interpret the thyroid function tests.
The patient has a low free T4 with an inappropriately normal TSH.
This laboratory pattern localizes the thyroid dysfunction to the pituitary or hypothalamus (central hypothyroidism) rather than a primary thyroid gland failure.
2
Identify the underlying etiology and associated risks based on history.
The history of severe traumatic brain injury 8 months prior suggests trauma-induced hypopituitarism, which typically affects multiple hormonal axes simultaneously.
Recognizing panhypopituitarism prompts a search for other life-threatening deficiencies, particularly central adrenal insufficiency.
3
Correlate with the physical examination and basic metabolic panel.
Orthostatic hypotension, nausea, and mild hyponatremia with normal potassium are classic signs of secondary adrenal insufficiency (loss of cortisol with preserved aldosterone).
These findings confirm that the adrenal axis is likely impaired and requires immediate attention.
4
Determine the safest sequence of management.
Evaluate and replace cortisol before administering thyroid hormone.
Initiating levothyroxine accelerates cortisol clearance. In a cortisol-deficient patient, this can rapidly precipitate a fatal Addisonian crisis.

Anahtar Kavram

In patients with suspected panhypopituitarism (e.g., following traumatic brain injury), adrenal insufficiency must be ruled out or treated prior to initiating levothyroxine therapy to prevent a life-threatening adrenal crisis.
Tahmini Süre:1m 30s
Soru 33Soru →

Match the following clinical and laboratory profiles of pediatric patients to the most likely underlying endocrine disorder.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

Elevated 1717-hydroxyprogesterone, hyponatremia, hyperkalemia, elevated plasma renin activity, and virilized external genitalia in a 46,XX46,\text{XX} newborn.
Hypertension, hypokalemia, elevated 1111-deoxycorticosterone, low cortisol, and female external genitalia in a 46,XY46,\text{XY} newborn.
Basal luteinizing hormone (LH) >0.3 mIU/mL> 0.3 \text{ mIU/mL}, robust LH surge following GnRH stimulation, and advanced bone age in a 66-year-old girl with breast development.
Low free thyroxine (T4\text{T}_4), markedly elevated thyroid-stimulating hormone (TSH), positive anti-thyroid peroxidase antibodies, and declining growth velocity in a 1212-year-old girl.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct matches are: Profile 1 (virilized 46,XX with salt wasting) matches Classic 21-hydroxylase deficiency. Profile 2 (46,XY with female genitalia and hypertension) matches 17-alpha-hydroxylase deficiency. Profile 3 (elevated LH and advanced bone age) matches Central precocious puberty. Profile 4 (low free T4 and high TSH) matches Hashimoto thyroiditis.
Each clinical profile uniquely corresponds to the pathophysiology of a specific pediatric endocrine disorder. Classic 21-hydroxylase deficiency leads to salt wasting and androgen excess. 17-alpha-hydroxylase deficiency leads to mineralocorticoid excess and androgen deficiency. Central precocious puberty is characterized by premature HPG axis activation. Hashimoto thyroiditis involves autoimmune destruction of the thyroid gland causing primary hypothyroidism.

Adım Adım Çözüm

1
Analyze the first profile presenting with hyponatremia, hyperkalemia, and virilization in a 46,XX infant.
Matches Classic 21-hydroxylase deficiency.
Lack of aldosterone causes salt wasting, while excess androgens virilize female infants. 17-hydroxyprogesterone is appropriately elevated.
2
Analyze the second profile presenting with hypertension, hypokalemia, and female genitalia in a 46,XY infant.
Matches 17-alpha-hydroxylase deficiency.
Lack of androgens prevents male genital development, while excess mineralocorticoid precursors (11-deoxycorticosterone) cause hypertension and hypokalemia.
3
Analyze the third profile presenting with pubertal LH levels (> 0.3 mIU/mL) and breast development in a 6-year-old.
Matches Central precocious puberty.
The robust LH surge to GnRH stimulation confirms gonadotropin-dependent (central) activation of the hypothalamic-pituitary-gonadal axis.
4
Analyze the fourth profile presenting with low free T4, high TSH, and anti-TPO antibodies.
Matches Hashimoto thyroiditis.
These laboratory findings confirm primary autoimmune hypothyroidism, a common cause of acquired short stature and delayed growth in adolescents.

Anahtar Kavram

Identifying characteristic clinical and hormonal patterns in pediatric endocrine disorders, specifically congenital adrenal hyperplasia variants, precocious puberty, and autoimmune thyroiditis.
Tahmini Süre:2m 0s
Soru 34Soru →

Match the following clinical presentations of suspected adrenal enzyme deficiencies with their most likely underlying diagnosis. Evaluate both the mineralocorticoid status and the degree of virilization to determine the correct enzyme defect.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 2-week-old 46,XX neonate presents with virilized external genitalia, failure to thrive, serum Na+Na^+ 124 mEq/L, and serum K+K^+ 6.8 mEq/L.
A 2-week-old 46,XX neonate presents with virilized external genitalia, a blood pressure of 115/75 mm Hg (elevated for age), serum Na+Na^+ 145 mEq/L, and serum K+K^+ 2.9 mEq/L.
A 16-year-old phenotypic female with a 46,XY karyotype presents with primary amenorrhea, absent secondary sexual characteristics, a blood pressure of 150/95 mm Hg, and serum K+K^+ 2.8 mEq/L.
A 2-week-old 46,XY neonate presents with hypospadias (undervirilized external genitalia), severe volume depletion, hyponatremia, hyperkalemia, and a markedly elevated 17-hydroxypregnenolone to 17-hydroxyprogesterone ratio.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The presentations match as follows: virilized/salt-wasting to 21-hydroxylase deficiency; virilized/hypertensive to 11-beta-hydroxylase deficiency; undervirilized/hypertensive to 17-alpha-hydroxylase deficiency; and undervirilized/salt-wasting (with elevated precursor ratio) to 3-beta-hydroxysteroid dehydrogenase deficiency.
Congenital adrenal hyperplasia and related DSDs encompass several distinct enzyme defects. Diagnosis relies systematically on determining the mineralocorticoid status (hypertension and hypokalemia versus hypotension and hyperkalemia) and the androgen status (virilization in 46,XX or undervirilization in 46,XY).

Adım Adım Çözüm

1
Evaluate blood pressure and potassium levels to determine mineralocorticoid effect.
Hyperkalemia and hyponatremia suggest aldosterone deficiency (21-hydroxylase or 3-beta-hydroxysteroid dehydrogenase). Hypokalemia and hypertension suggest excess mineralocorticoids (11-beta-hydroxylase or 17-alpha-hydroxylase).
This establishes the horizontal pathway of the steroidogenic block.
2
Evaluate the karyotype and external genitalia to determine androgen status.
Virilization in a 46,XX neonate indicates excess androgens (21-hydroxylase or 11-beta-hydroxylase). Undervirilization in a 46,XY neonate indicates deficient potent testosterone production (17-alpha-hydroxylase or 3-beta-hydroxysteroid dehydrogenase).
This establishes the vertical pathway of the steroidogenic block.
3
Combine the findings to isolate the specific enzyme deficiency.
Matching the mineralocorticoid and androgen profiles perfectly isolates each of the four classical congenital adrenal hyperplasia variants.
Enzyme defects create distinct accumulations of upstream precursors and deficiencies of downstream products.

Anahtar Kavram

Congenital Adrenal Hyperplasia (CAH) Enzyme Deficiencies
Soru 35Soru →

An 88-month-old boy is evaluated in the pediatric emergency department for irritability, poor feeding, and passing copious amounts of dilute-appearing urine over the past three days. His parents report that he frequently demands breast milk or water but often vomits shortly afterward. His birth and prenatal history were unremarkable. He is currently at the 55 th percentile for weight and 2525 th percentile for length, having dropped from the 5050 th percentile for weight at his 44-month visit. Temperature is 37.1∘C37.1^\circ\text{C} (98.8∘F98.8^\circ\text{F}), blood pressure is 85/50 mm Hg85/50 \text{ mm Hg}, and pulse is 160/min160/\text{min}. Physical examination shows dry mucous membranes, a sunken anterior fontanelle, and poor skin turgor. Initial laboratory studies show:

Serum sodium: 154 mEq/L154 \text{ mEq/L}
Serum potassium: 4.0 mEq/L4.0 \text{ mEq/L}
Serum osmolality: 318 mOsm/kg H2O318 \text{ mOsm/kg H}_2\text{O}
Urine osmolality: 95 mOsm/kg H2O95 \text{ mOsm/kg H}_2\text{O}

The patient is admitted, and subcutaneous desmopressin is administered. Two hours later, a repeat urine osmolality is 105 mOsm/kg H2O105 \text{ mOsm/kg H}_2\text{O}. Which of the following is the most appropriate long-term pharmacotherapy to reduce polyuria in this patient?

Cevabı ve açıklamayı göster

Cevap: Hydrochlorothiazide

Cevap

The most appropriate long-term pharmacotherapy for this patient is Hydrochlorothiazide.
The correct answer is hydrochlorothiazide. This infant's presentation of hypernatremia, serum hyperosmolality, and inappropriately dilute urine confirms diabetes insipidus. The lack of a significant increase in urine osmolality following the administration of exogenous desmopressin (an ADH analog) indicates renal resistance to ADH, definitively diagnosing nephrogenic diabetes insipidus (NDI). The paradoxical first-line pharmacologic treatment for NDI is a thiazide diuretic (often combined with a low-solute diet or NSAIDs like indomethacin). Thiazides induce a mild state of hypovolemia, which stimulates the proximal tubule to increase the reabsorption of sodium and water. This physiological compensation decreases the volume of filtrate delivered to the distal nephron and ADH-resistant collecting ducts, ultimately reducing total polyuria.

Adım Adım Çözüm

1
Analyze the initial clinical and laboratory presentation.
The infant presents with severe hypernatremic dehydration (154 mEq/L154 \text{ mEq/L}) and hyperosmolality (318 mOsm/kg H2O318 \text{ mOsm/kg H}_2\text{O}) alongside inappropriately dilute urine (95 mOsm/kg H2O95 \text{ mOsm/kg H}_2\text{O}), establishing a diagnosis of diabetes insipidus (DI).
High serum sodium and osmolality with low urine osmolality defines the inability to concentrate urine, characteristic of DI.
2
Interpret the result of the desmopressin administration.
The urine osmolality remains highly dilute (105 mOsm/kg H2O105 \text{ mOsm/kg H}_2\text{O}) after exogenous desmopressin, indicating an absent renal response.
Failure to concentrate urine by at least 50%50\% following ADH analog administration distinguishes nephrogenic DI from central DI.
3
Determine the optimal pharmacologic management for the established diagnosis.
The patient requires therapy for nephrogenic DI, which involves a low-solute diet and a thiazide diuretic such as hydrochlorothiazide.
Thiazides paradoxically reduce urine output in NDI by causing mild hypovolemia, which enhances proximal tubule reabsorption of sodium and water, reducing delivery to the ADH-resistant collecting ducts.

Anahtar Kavram

Nephrogenic diabetes insipidus diagnosis and paradoxical treatment with thiazide diuretics.
Soru 36Soru →

A 99-month-old boy is brought to the clinic for a routine evaluation. His parents are concerned because he is not yet sitting without support and seems less active than his older siblings were at this age. He was born at 4040 weeks gestation following an uncomplicated pregnancy. The state newborn screening, which utilizes a primary thyroid-stimulating hormone (TSH) assay, was reported as normal. Over the last six months, his length has fallen from the 5050 th to the 55 th percentile, and his weight has fallen from the 4040 th to the 1010 th percentile. On physical examination, the infant has generalized hypotonia, a prominent forehead, and a remarkably small phallus.

Laboratory testing reveals the following:

Laboratory TestResultReference Range
Serum free thyroxine (T4)0.50.5 ng/dL0.90.9-2.32.3 ng/dL
Serum thyroid-stimulating hormone (TSH)2.22.2 mIU/L0.50.5-5.05.0 mIU/L
Serum glucose5555 mg/dL7070-100100 mg/dL

Which of the following is the most likely underlying cause of this patient's clinical and laboratory findings?

Cevabı ve açıklamayı göster

Cevap: Deficient secretion of anterior pituitary hormones

Cevap

Deficient secretion of anterior pituitary hormones
The correct answer identifies central (secondary) hypothyroidism as part of a broader congenital hypopituitarism syndrome. The patient has a low free T4 level with an inappropriately normal TSH, indicating a central defect rather than a primary thyroid gland issue. The presence of a remarkably small phallus (micropenis) and hypoglycemia strongly suggests concomitant growth hormone (GH) and gonadotropin deficiency, which is classic for congenital hypopituitarism. Notably, newborn screening programs that rely primarily on TSH assays often miss central hypothyroidism because TSH levels are not elevated.

Adım Adım Çözüm

1
Interpret the thyroid function tests.
The free T4 is abnormally low, but the TSH is within the normal range.
A low free T4 should normally trigger a robust TSH elevation via negative feedback. An inappropriately normal TSH in the setting of low T4 indicates a central (pituitary or hypothalamic) defect, known as central hypothyroidism.
2
Evaluate the clinical signs and other laboratory findings in the context of a central endocrine defect.
The patient has hypoglycemia, growth failure, and a small phallus (micropenis).
These findings point to additional anterior pituitary hormone deficiencies. Growth hormone (GH) and adrenocorticotropic hormone (ACTH) deficiencies cause hypoglycemia and growth failure. Gonadotropin (LH/FSH) and GH deficiencies during fetal development result in a micropenis.
3
Synthesize the findings to determine the underlying etiology.
The combination of central hypothyroidism with suspected GH, ACTH, and gonadotropin deficiencies indicates panhypopituitarism.
Congenital hypopituitarism perfectly explains the broad spectrum of metabolic and developmental abnormalities seen in this infant.

Anahtar Kavram

Congenital Hypopituitarism and Central Hypothyroidism
Soru 37Soru →

A 1212-year-old adolescent is brought to the emergency triage in a lethargic state. The parents note a three-week history of unquenchable thirst, frequent nighttime urination, and a 4-kg4\text{-kg} weight loss. Clinical examination reveals deep, rapid respirations and a heart rate of 135/min135\text{/min}. Point-of-care testing shows a capillary blood glucose of 580 mg/dL580 \text{ mg/dL}. A venous blood gas demonstrates a pH of 7.087.08 and a calculated anion gap of 24 mEq/L24 \text{ mEq/L}. The patient is diagnosed with severe diabetic ketoacidosis (DKA). Arrange the following therapeutic interventions in the appropriate chronological order, reflecting the standard pediatric endocrine protocol to safely correct the metabolic derangement while minimizing the risk of cerebral edema.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence is: 1) Intravenous bolus of 0.9% sodium chloride, 2) Continuous intravenous insulin infusion, 3) Addition of 5% dextrose to fluids, and 4) Administration of subcutaneous basal insulin.
The correct chronological order for pediatric DKA management relies on strict physiological priorities: volume resuscitation is the absolute first step to prevent shock. Continuous insulin follows to slowly correct acidosis. Dextrose is added to prevent hypoglycemia while insulin continues to clear ketones. Finally, a transition to subcutaneous insulin is made with an overlap period once the anion gap is fully closed.

Adım Adım Çözüm

1
Assess the patient's hemodynamic status and recognize the immediate threat in severe DKA.
Identify that severe osmotic diuresis has caused critical volume depletion, making fluid resuscitation the first priority.
Administering insulin before restoring intravascular volume can cause cardiovascular collapse and increase the risk of cerebral edema.
2
Address the underlying ketogenesis and metabolic acidosis.
Start a continuous intravenous insulin infusion without a bolus.
A steady state of insulin suppresses lipolysis and ketone production. In pediatrics, a continuous drip is started after fluid expansion to ensure safe, gradual correction of serum osmolality.
3
Monitor serum glucose in relation to the anion gap during treatment.
Add dextrose to the maintenance fluids when glucose falls to the 250-300 mg/dL range.
Ketone clearance lags behind glucose clearance. Dextrose prevents hypoglycemia, allowing the insulin infusion to continue running until the acidosis (anion gap) fully resolves.
4
Determine the criteria for transitioning off intravenous therapy.
Administer subcutaneous insulin and overlap it with the intravenous drip for 1 to 2 hours once the anion gap closes.
Intravenous regular insulin has a very short half-life (minutes). Stopping it without overlapping subcutaneous insulin will result in rapid rebound ketoacidosis.

Anahtar Kavram

Pediatric Diabetic Ketoacidosis (DKA) Acute Management Protocol
Soru 38Soru →

An 8-year-old girl is referred to the pediatric endocrinology clinic for evaluation of growth failure. Her parents report that she is the shortest in her class and has not needed a larger shoe size or new clothing sizes in the past two years. Review of her growth chart shows a height that has crossed two major percentile lines downward over the last 30 months, currently resting below the 1st percentile. Her weight is tracking consistently at the 45th percentile. She has no history of headaches, visual changes, gastrointestinal symptoms, or cold intolerance. Physical examination is unremarkable, with normal visual fields and Tanner stage 1 pubertal development. Arrange the following diagnostic and management steps in the most appropriate chronological order for evaluating this patient's growth deceleration.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence for evaluating pathological short stature is to first rule out systemic and thyroid conditions with basic labs and a bone age scan, followed by screening the GH axis with IGF-1, confirming GH deficiency with provocative testing, performing a pituitary MRI to identify the etiology, and finally initiating rhGH therapy.
The evaluation of pathological short stature requires a rigorous stepwise approach to avoid unnecessary, invasive, and expensive testing. Because the patient's weight is preserved while her height is dropping, an endocrine etiology (rather than malnutrition or malabsorption, which typically affects weight first) is highly suspected. However, basic screening (bone age, TSH, celiac panel) is always the first step. Once systemic causes are excluded, the GH axis is evaluated. Because random GH levels are uninterpretable due to pulsatile secretion, IGF-1 and IGFBP-3 are the initial screening markers. Low levels mandate provocative GH testing (using agents like clonidine or glucagon) to definitively diagnose deficiency. Finally, an MRI of the hypothalamic-pituitary region is required to rule out structural anomalies (like craniopharyngioma) before starting recombinant GH therapy.

Adım Adım Çözüm

1
Exclude systemic disease and evaluate bone maturation.
Normal TSH, normal celiac screen, and delayed bone age.
Growth deceleration is a non-specific sign; common non-pituitary causes (hypothyroidism, celiac disease) must be ruled out before testing the GH axis.
2
Screen the somatotropic (growth hormone) axis.
Low serum IGF-1 and IGFBP-3 levels.
GH is secreted in a pulsatile manner, so random GH levels are clinically useless. IGF-1 provides a stable marker of integrated GH secretion.
3
Confirm growth hormone deficiency.
Peak GH response below standard diagnostic thresholds during provocative testing.
IGF-1 can be falsely low due to poor nutrition. Provocative testing forces the pituitary to secrete GH; failure to do so confirms the diagnosis.
4
Identify the underlying etiology via neuroimaging.
MRI evaluates for tumors (e.g., craniopharyngioma) or congenital malformations.
rhGH therapy is contraindicated in the presence of active malignancy. Structural lesions must be ruled out once GHD is confirmed.
5
Treat the confirmed condition.
Initiation of rhGH therapy.
Definitive treatment can only begin safely after the diagnosis is biochemically proven and anatomical lesions are excluded.

Anahtar Kavram

Evaluation of pathological short stature and suspected growth hormone deficiency
Soru 39Soru →

During a routine kindergarten physical, the physician notes that a 5-year-old boy has grown significantly faster than his peers. His parents report that he has developed axillary hair and adult-like body odor over the last six months. He is otherwise healthy and takes no medications. Vital signs show a blood pressure of 134/86 mm Hg134/86\text{ mm Hg} (greater than the 99th percentile for his age and height). Physical examination reveals a muscular habitus and moderate facial acne. Genitourinary examination demonstrates Tanner stage III pubic hair, an enlarged phallus, and bilateral testicular volumes of 2 mL2\text{ mL}. Radiographic imaging of the left wrist indicates a bone age of 9 years, and his serum testosterone is markedly elevated. Which of the following laboratory abnormalities is most likely to be found in this patient?

Cevabı ve açıklamayı göster

Cevap: Decreased plasma renin activity

Cevap

Decreased plasma renin activity is the correct expected finding in this patient.
The correct answer is decreased plasma renin activity. This patient presents with signs of peripheral precocious puberty (advanced bone age, pubic hair, elevated testosterone, but prepubertal testicular volume of <4 mL< 4\text{ mL}) accompanied by significant hypertension. This clinical picture is highly characteristic of 11-beta-hydroxylase deficiency, the second most common form of congenital adrenal hyperplasia. The lack of 11-beta-hydroxylase prevents the conversion of 11-deoxycorticosterone to corticosterone, and 11-deoxycortisol to cortisol. The resulting decrease in cortisol removes negative feedback on the pituitary, leading to increased adrenocorticotropic hormone (ACTH) secretion. Elevated ACTH drives the accumulation of adrenal androgens (causing virilization and peripheral precocious puberty) and 11-deoxycorticosterone. Because 11-deoxycorticosterone is a potent mineralocorticoid, its massive accumulation leads to sodium retention, volume expansion, and hypertension. This volume expanded state subsequently suppresses renin production by the juxtaglomerular cells of the kidney, resulting in decreased plasma renin activity.

Adım Adım Çözüm

1
Analyze the patient's presentation of precocious puberty.
The patient has advanced virilization, rapid growth, and elevated testosterone, but prepubertal testicular volume (2 mL2\text{ mL}).
This combination differentiates gonadotropin-independent (peripheral) precocious puberty (small testes due to lack of LH/FSH stimulation) from gonadotropin-dependent (central) precocious puberty (enlarged testes).
2
Integrate the vital signs with the hormonal findings.
The patient has severe hypertension alongside peripheral precocious puberty.
The combination of peripheral androgen excess and mineralocorticoid excess strongly points toward a specific congenital adrenal hyperplasia variant, namely 11-beta-hydroxylase deficiency.
3
Deduce the laboratory profile of 11-beta-hydroxylase deficiency.
The enzymatic block leads to the accumulation of 11-deoxycorticosterone.
11-deoxycorticosterone acts as a strong mineralocorticoid, causing sodium and water retention. This volume expansion inherently suppresses plasma renin activity.

Anahtar Kavram

Pathophysiology and clinical presentation of 11-beta-hydroxylase deficiency
Soru 40Soru →

Match each clinical presentation of a pediatric patient with the most likely underlying endocrine condition.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 2-week-old female infant with ambiguous genitalia, poor feeding, vomiting, hyponatremia, and hyperkalemia.
A 3-year-old girl with clitoromegaly, rapid somatic growth, hypertension, and hypokalemia.
A 16-year-old phenotypic female with primary amenorrhea, absent pubic hair, hypertension, and hypokalemia.
A 6-year-old girl with isolated bilateral breast enlargement, normal growth velocity, and bone age equal to chronological age.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The first presentation matches 21-hydroxylase deficiency, the second matches 11β-hydroxylase deficiency, the third matches 17α-hydroxylase deficiency, and the fourth matches Premature thelarche.
The matches successfully pair each clinical syndrome with its underlying pathophysiology based on the specific presence or absence of mineralocorticoid effects (blood pressure, potassium levels) and sex steroid effects (virilization, amenorrhea).

Adım Adım Çözüm

1
Analyze the first presentation for signs of virilization and electrolyte abnormalities.
The infant has ambiguous genitalia (virilization) and salt-wasting (hyponatremia, hyperkalemia), pointing to a block in both aldosterone and cortisol synthesis with shunting to androgens.
Identifying both androgen excess and mineralocorticoid deficiency isolates 21-hydroxylase deficiency.
2
Analyze the second presentation for virilization and blood pressure status.
The girl has virilization but presents with hypertension and hypokalemia, indicating mineralocorticoid excess.
11β-hydroxylase deficiency blocks cortisol and aldosterone but leads to a buildup of 11-deoxycorticosterone (a weak mineralocorticoid) and shunts precursors to androgens.
3
Analyze the third presentation for sexual development and blood pressure status.
The patient is a phenotypic female with absent secondary sexual characteristics (no androgens/estrogens) and hypertension/hypokalemia (mineralocorticoid excess).
17α-hydroxylase deficiency blocks both the glucocorticoid and sex steroid pathways, shunting all precursors to the mineralocorticoid pathway.
4
Analyze the fourth presentation for signs of true puberty versus benign variants.
The girl has breast development but normal growth velocity and bone age.
The absence of advanced bone age or rapid growth rules out central precocious puberty, confirming benign premature thelarche.

Anahtar Kavram

Clinical differentiation of congenital adrenal hyperplasia enzyme deficiencies and benign pubertal variants.
ÖncekiSayfa 2 / 3Sonraki